Avandia Linked To Over 300 Deaths In 3rd Quarter Of 2009

GlaxoSmithKline’s (GSK) Type 2 diabetes drug, Avandia, has been linked to over 300 deaths in the third quarter of 2009 alone according to secret government documents obtained by the New York Times. This staggering number has prompted the U.S. Food & Drug Administration (FDA) to reassess the drug’s future in meetings this summer.

→ Read More

Avandia Side Effects – Heart Attack

An increased risk of heart attack and other cardiovascular problems have been linked to Avandia, GlaxoSmithKline’s best-selling drug for the treatment of Type 2 diabetes, in a recent meta-analysis.

→ Read More